Hong Kong · Delayed Price · Currency is HKD Wuhan YZY Biopharma Statistics
Total Valuation
HKG:2496 has a market cap or net worth of HKD 934.35 million. The enterprise value is 965.17 million.
| Market Cap | 934.35M |
| Enterprise Value | 965.17M |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2496 has 193.85 million shares outstanding.
| Current Share Class | 179.48M |
| Shares Outstanding | 193.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.52% |
| Owned by Institutions (%) | 8.61% |
| Float | 21.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.97 |
| PB Ratio | -15.83 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.24 |
| EV / Sales | 11.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.66
| Current Ratio | 0.66 |
| Quick Ratio | 0.57 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -22.74% |
| Return on Invested Capital (ROIC) | -43.29% |
| Return on Capital Employed (ROCE) | 315.57% |
| Weighted Average Cost of Capital (WACC) | 5.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 106 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 14.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.66% in the last 52 weeks. The beta is 0.34, so HKG:2496's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +3.66% |
| 50-Day Moving Average | 5.94 |
| 200-Day Moving Average | 6.36 |
| Relative Strength Index (RSI) | 42.01 |
| Average Volume (20 Days) | 880 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2496 had revenue of HKD 85.20 million and -94.29 million in losses. Loss per share was -0.49.
| Revenue | 85.20M |
| Gross Profit | 22.75M |
| Operating Income | -89.65M |
| Pretax Income | -94.29M |
| Net Income | -94.29M |
| EBITDA | -83.00M |
| EBIT | -89.65M |
| Loss Per Share | -0.49 |
Balance Sheet
The company has 111.35 million in cash and 142.17 million in debt, with a net cash position of -30.82 million or -0.16 per share.
| Cash & Cash Equivalents | 111.35M |
| Total Debt | 142.17M |
| Net Cash | -30.82M |
| Net Cash Per Share | -0.16 |
| Equity (Book Value) | -59.01M |
| Book Value Per Share | -0.30 |
| Working Capital | -76.38M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 6.85M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 26.70%, with operating and profit margins of -105.22% and -110.67%.
| Gross Margin | 26.70% |
| Operating Margin | -105.22% |
| Pretax Margin | -110.67% |
| Profit Margin | -110.67% |
| EBITDA Margin | -97.42% |
| EBIT Margin | -105.22% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2496 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -10.09% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |